OBJECTIVE: Epstein-Barr virus (EBV) is a ubiquitous human herpesvirus that becomes latent in B-lymphocytes and has been implicated in the pathogenesis of multiple sclerosis (MS). We searched for latent and active EBV infection in MS brain and CSF. METHODS: Nested and non-nested real-time PCR were used to detect cell-specific and EBV-specific transcripts in 15 fresh-frozen and 5 formalin-fixed paraffin-embedded MS plaques and in single MS CSF B-lymphocytes and plasma cells. Intrathecal anti-EBV antibody synthesis was measured by ELISA. Immunocytochemistry was used to detect binding of MS CSF and recombinant antibodies (rAbs) generated from clonally expanded plasma cells in MS CSF to EBV-infected cells. RESULTS: No EBV RNA was found in MS CSF B-lymphocytes or plasma cells. In active MS plaques, EBV-encoded RNA (EBER)-1 was the only and rarely detected transcript. The frequency of detected intrathecal anti-EBV antibody synthesis in patients with MS did not differ from that in non-MS inflammatory CNS disease control patients. Anti-EBV antibodies were detected in the CSF of patients with MS, but MS rAbs did not react with EBV. CONCLUSIONS: Application of real-time PCR to multiple sclerosis brain and single B-lymphocytes in CSF did not reveal any evidence of active Epstein-Barr virus infection.
OBJECTIVE: Epstein-Barr virus (EBV) is a ubiquitous humanherpesvirus that becomes latent in B-lymphocytes and has been implicated in the pathogenesis of multiple sclerosis (MS). We searched for latent and active EBV infection in MS brain and CSF. METHODS: Nested and non-nested real-time PCR were used to detect cell-specific and EBV-specific transcripts in 15 fresh-frozen and 5 formalin-fixed paraffin-embedded MS plaques and in single MS CSF B-lymphocytes and plasma cells. Intrathecal anti-EBV antibody synthesis was measured by ELISA. Immunocytochemistry was used to detect binding of MS CSF and recombinant antibodies (rAbs) generated from clonally expanded plasma cells in MS CSF to EBV-infected cells. RESULTS: No EBV RNA was found in MS CSF B-lymphocytes or plasma cells. In active MS plaques, EBV-encoded RNA (EBER)-1 was the only and rarely detected transcript. The frequency of detected intrathecal anti-EBV antibody synthesis in patients with MS did not differ from that in non-MS inflammatory CNS disease control patients. Anti-EBV antibodies were detected in the CSF of patients with MS, but MS rAbs did not react with EBV. CONCLUSIONS: Application of real-time PCR to multiple sclerosis brain and single B-lymphocytes in CSF did not reveal any evidence of active Epstein-Barr virus infection.
Authors: Gregory P Owens; Alanna M Ritchie; Mark P Burgoon; R Anthony Williamson; John R Corboy; Donald H Gilden Journal: J Immunol Date: 2003-09-01 Impact factor: 5.422
Authors: Kimberly M Winges; Donald H Gilden; Jeffrey L Bennett; Xiaoli Yu; Alanna M Ritchie; Gregory P Owens Journal: J Neuroimmunol Date: 2007-11-13 Impact factor: 3.478
Authors: A Ascherio; K L Munger; E T Lennette; D Spiegelman; M A Hernán; M J Olek; S E Hankinson; D J Hunter Journal: JAMA Date: 2001-12-26 Impact factor: 56.272
Authors: Alanna M Ritchie; Donald H Gilden; R Anthony Williamson; Mark P Burgoon; Xiaoli Yu; Karen Helm; John R Corboy; Gregory P Owens Journal: J Immunol Date: 2004-07-01 Impact factor: 5.422
Authors: Mark P Burgoon; Barbara N Hammack; Gregory P Owens; Amy L Maybach; M Judith Eikelenboom; Donald H Gilden Journal: Ann Neurol Date: 2003-10 Impact factor: 10.422
Authors: A Bräuninger; T Spieker; K Willenbrock; P Gaulard; H H Wacker; K Rajewsky; M L Hansmann; R Küppers Journal: J Exp Med Date: 2001-10-01 Impact factor: 14.307
Authors: Marius Birlea; Gabriele Arendt; Eser Orhan; D Scott Schmid; William J Bellini; Christian Schmidt; Don Gilden; Randall J Cohrs Journal: J Neurol Sci Date: 2011-03-17 Impact factor: 3.181